Seritage Growth Properties
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| SERITAGE GROWTH PROPERTIES | |
| Dated: March 31, 2025 | /s/ Andrea Olshan |
|---|
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Andrea Olshan | Chief Executive Officer and President(principal executive officer) | March 31, 2025 |
| Andrea Olshan | ||
| /s/ John Garilli | Interim Chief Financial Officer (principal financial and accounting officer) | March 31, 2025 |
| John Garilli | ||
| /s/ Adam Metz | Trustee | March 31, 2025 |
| Adam Metz | ||
| /s/ John T. McClain | Trustee | March 31, 2025 |
| John T. McClain | ||
| /s/ Mitchell Sabshon | Trustee | March 31, 2025 |
| Mitchell Sabshon | ||
| /s/ Talya Nevo-Hacohen | Trustee | March 31, 2025 |
| Talya Nevo-Hacohen | ||
| /s/ Allison Thrush | Trustee | March 31, 2025 |
| Allison Thrush | ||
| /s/ Mark Wilsmann | Trustee | March 31, 2025 |
| Mark Wilsmann | ||
-54 -
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
AND CONSOLIDATED FINANCIAL STATEMENT SCHEDULE
Financial Statements
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 34) | F-2 |
|---|---|
| Consolidated Balance Sheets as of December 31, 2024 and 2023 | F-5 |
| Consolidated Statements of Operations for the years ended December 31, 2024 and 2023 | F-6 |
| Consolidated Statements of Equity for the years ended December 31, 2024 and 2023 | F-7 |
| Consolidated Statements of Cash Flows for the years ended December 31, 2024 and 2023 | F-8 |
| Notes to Consolidated Financial Statements | F-10 |
| Financial Statement Schedule | |
| Schedule III—Real estate and accumulated depreciation | F-32 |
All other schedules are omitted since the required information is either not present in any amounts, is not present in amounts sufficient to require submission of the schedule or because the information required is included in the consolidated financial statements and related notes.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.